Sort by
Nursing and Health Professions
Palliative Therapy
91%
Quality of Life
72%
Multiple Myeloma
56%
Systematic Review
56%
Diseases
51%
Myeloma
38%
Malignant Neoplasm
37%
Multiple Sclerosis
29%
Meta Analysis
28%
Dyspnea
25%
Prevalence
23%
Treatment Outcome
21%
Terminal Care
19%
Congestive Heart Failure
18%
Dying
18%
Advanced Cancer
14%
Lung Cancer
13%
Confidence Interval
10%
Quality of Life Measure
10%
Obstructive Lung Disease
9%
Emergency Ward
9%
Chronic Kidney Failure
9%
Health Care Need
9%
Hypnotherapy
9%
Longitudinal Analysis
9%
Chronic Respiratory Tract Disease
9%
Follicular Lymphoma
9%
Social Support
9%
Wasting Syndrome
9%
End Stage Renal Disease
9%
Androgen Therapy
9%
Drug Therapy
9%
Human immunodeficiency virus
9%
Placebo
9%
Chronic Lung Disease
8%
Symptom Assessment
7%
Lean Body Weight
7%
Service Development
7%
Patient Referral
6%
Health Care Utilization
6%
Body Weight
5%
PsycINFO
5%
Embase
5%
Cochrane Library
5%
Medicine and Dentistry
Symptomatic Treatment
100%
Diseases
38%
Multiple Myeloma
37%
Systematic Review
37%
Malignant Neoplasm
32%
Dyspnea
32%
Quality of Life
30%
Meta-Analysis
20%
End of Life Care
20%
Multiple Sclerosis
19%
Health Care Cost
18%
Randomized Controlled Trial
17%
COVID-19
15%
Patient Referral
14%
Prevalence
13%
Myeloma
12%
Lung Cancer
11%
Symptom Management
11%
Advanced Cancer
10%
Chronic Obstructive Pulmonary Disease
9%
Chronic Respiratory Tract Disease
9%
Terminal Illness
9%
End Stage Renal Disease
9%
Emergency Department
9%
Medical Research
9%
Hypnotherapy
9%
Hospital-Based Palliative Care
9%
Phase II Trials
9%
Dying
9%
Social Support
9%
Congestive Heart Failure
9%
Hypercalcaemia
9%
Cancer
9%
Bisphosphonate
9%
Chronic Lung Disease
8%
Clodronic Acid
7%
Caregiver Burden
6%
Etidronic Acid
5%
Pamidronic Acid
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bisphosphonic Acid Derivative
28%
Dyspnea
20%
Chronic Obstructive Lung Disease
18%
Diseases
18%
Placebo
17%
Hypercalcaemia
14%
Malignant Neoplasm
12%
Randomized Controlled Trial
11%
Multiple Myeloma
10%
Clodronic Acid
10%
HIV
9%
Congestive Heart Failure
9%
Wasting Syndrome
9%
Etidronic Acid
6%
Pamidronic Acid
6%
Myeloma
6%
Observational Study
6%
Bone Metastasis
5%
